Digital Diabetes Management Market Report: Trends, Forecast and Competitive Analysis to 2030

Digital Diabetes Management Trends and Forecast

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

A more than 150-page report is developed to help in your business decisions.

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management by product, type, end use, and region

Digital Diabetes Management Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management Market Insights

Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Within this market, hospitals will remain the largest segment due to increasing adoption of digital technologies for remote patient monitoring and easy availability of advanced digital diabetes management tools in hospitals.

North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the digital diabetes management market size?

Answer: The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030.

Q.2 What is the growth forecast for digital diabetes management market?

Answer: The global digital diabetes management market is expected to grow with a CAGR of 10.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the digital diabetes management market?

Answer: The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

Q4. What are the major segments for digital diabetes management market?

Answer: The future of the digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets.

Q5. Who are the key digital diabetes management market companies?

Answer: Some of the key digital diabetes management companies are as follows:

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Q6. Which digital diabetes management market segment will be the largest in future?

Answer: Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Q7. In digital diabetes management market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps ), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?